Key facts
- This page summarizes Peter Luo's Form 3 filing for Adagene Inc. (ADAG).
- 0 reported transactions and 16 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 09:04.
Peter Luo - 18 Mar 2026 Form 3 Insider Report for Adagene Inc. (ADAG)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ADAG
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Peter LUO
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Peter Luo filed Form 3 for Adagene Inc. (ADAG) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001907614
Primary reporting owner
Luo Peter
- Relationship
- Chief Executive Officer, Director
- Address
- 4F, BUILDING C14, NO. 218 XINGHU STREET, SUZHOU JIANGSU, CHINA
- Signature
- /s/ Peter LUO
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADAG
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 93,264
- Date
- 18 Mar 2026
- Ownership
- Direct
ADAG
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 31,021
- Date
- 18 Mar 2026
- Ownership
- By Spouse
ADAG
holding
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 168,750
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
ADAG
holding
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,000
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 287,415
- Exercise price
- $13.85
- Footnotes
- F3
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- $5.60
- Footnotes
- F4
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 500,000
- Exercise price
- $1.04
- Footnotes
- F5
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 500,000
- Exercise price
- $1.33
- Footnotes
- F6
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 822,819
- Exercise price
- $1.73
- Footnotes
- F7
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 450,000
- Exercise price
- $1.55
- Footnotes
- F8
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 735,000
- Exercise price
- $1.41
- Footnotes
- F9
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 800,000
- Exercise price
- $2.03
- Footnotes
- F10
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 45,980
- Exercise price
- $13.85
- Footnotes
- F11
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,250
- Exercise price
- $5.60
- Footnotes
- F12
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 100,000
- Exercise price
- $1.05
- Footnotes
- F13
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 100,000
- Exercise price
- $1.17
- Footnotes
- F14
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 152,322
- Exercise price
- $1.73
- Footnotes
- F15
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 80,000
- Exercise price
- $1.55
- Footnotes
- F16
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 130,700
- Exercise price
- $1.41
- Footnotes
- F17
ADAG
holding
Derivative
Incentive Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- By Spouse
- Underlying class
- Ordinary Shares
- Underlying amount
- 150,000
- Exercise price
- $2.03
- Footnotes
- F18
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 18 footnotes
Footnote F1
168,750 of Restricted Stock Units ("RSUs") granted under the Adagene Inc. 2021 Performance Incentive Plan. 56,250 of RSUs shall vest on each of the following dates: 7/23/2026, 7/23/2027, and 7/23/2028.
Footnote F2
75,000 of RSUs granted under the Adagene Inc. 2021 Performance Incentive Plan. 25,000 of RSUs should be vested annually on each of the following dates: 7/23/2026, 7/23/2027, and 7/23/2028.
Footnote F3
287,415 of time-based incentive stock options granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such option are fully vested and exercisable.
Footnote F4
50,000 of performance-based stock options granted under the Adagene Inc. 2021 Performance Incentive Plan, and all such option are fully vested and exercisable.
Footnote F5
500,000 of time-based stock option granted on 5/3/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 250,000 shares subject to this option are vested and exercisable.
Footnote F6
500,000 of time-based stock option granted on 12/27/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 250,000 shares subject to this option are vested and exercisable.
Footnote F7
822,819 of time-based stock option granted on 11/17/2024 under the Adagene Inc. 2021 Performance Incentive Plan. 50% of the options shall vest on 6/30/2025 and 6/30/2026, respectively; accordingly, 411,410 shares subject to this option are vested and exercisable.
Footnote F8
450,000 of time-based stock option granted on 12/24/2024 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly,112,500 shares subject to this option are vested and exercisable.
Footnote F9
735,000 of time-based stock option granted on 6/5/2025 under the Adagene Inc. 2021 Performance Incentive Plan, and shall become exercisable with respect to 25% of the stock options on each of the first four anniversaries of the grant.
Footnote F10
800,000 of time-based stock option granted on 2/5/2026 under the Adagene Inc. 2021 Performance Incentive Plan, and shall become exercisable with respect to 25% of the stock options on each of the first four anniversaries of the grant.
Footnote F11
45,980 of time-based incentive stock options granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such shares subject to this option are fully vested and exercisable.
Footnote F12
2,250 of performance-based stock options granted under the Adagene Inc. 2021 Performance Incentive Plan, and all such shares subject to this option are fully vested and exercisable.
Footnote F13
100,000 of time-based stock option granted on 5/9/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 50,000 shares subject to this option are vested and exercisable.
Footnote F14
100,000 of time-based stock option granted on 12/18/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 50,000 shares subject to this option are vested and exercisable.
Footnote F15
152,322 of time-based stock option granted on 11/17/2024 under the Adagene Inc. 2021 Performance Incentive Plan. 50% of the options shall vest on 6/30/2025 and 6/30/2026, respectively; accordingly, 76,161 shares subject to this option became vested and exercisable.
Footnote F16
80,000 of time-based stock option granted on 12/24/2024 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 20,000 shares subject to this option are vested and exercisable.
Footnote F17
130,700 of time-based stock option granted on 6/5/2025 under the Adagene Inc. 2021 Performance Incentive Plan, and became exercisable with respect to 25% of the stock options on each of the first four anniversaries of the grant.
Footnote F18
150,000 of time-based stock option granted on 2/5/2026 under the Adagene Inc. 2021 Performance Incentive Plan, and became exercisable with respect to 25% of the stock options on each of the first four anniversaries of the grant.